| __timestamp | Bio-Techne Corporation | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 12404000 |
| Thursday, January 1, 2015 | 40853000 | 18343000 |
| Friday, January 1, 2016 | 45187000 | 18108000 |
| Sunday, January 1, 2017 | 53514000 | 17614000 |
| Monday, January 1, 2018 | 55329000 | 35619000 |
| Tuesday, January 1, 2019 | 62413000 | 58432000 |
| Wednesday, January 1, 2020 | 65192000 | 63945000 |
| Friday, January 1, 2021 | 70603000 | 72200000 |
| Saturday, January 1, 2022 | 87140000 | 76642000 |
| Sunday, January 1, 2023 | 92493000 | 57519000 |
| Monday, January 1, 2024 | 96664000 |
Infusing magic into the data realm
In the ever-evolving biotech industry, research and development (R&D) are the lifeblood of innovation. Over the past decade, Bio-Techne Corporation and Evotec SE have been at the forefront, investing heavily in R&D to drive breakthroughs. From 2014 to 2023, Bio-Techne's R&D expenses surged by over 200%, reflecting a robust commitment to innovation. In contrast, Evotec SE's R&D spending grew by approximately 360% until 2022, showcasing its aggressive pursuit of scientific advancements.
Bio-Techne consistently increased its R&D budget, peaking in 2024, while Evotec SE's data for 2024 remains unavailable. This trend underscores Bio-Techne's sustained growth and Evotec's strategic focus on R&D until recent years. As these companies continue to push the boundaries of biotechnology, their R&D investments highlight the critical role of innovation in shaping the future of healthcare.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Veracyte, Inc.
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds